Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

253.91 USD -4.69 (-1.81%)
Streaming Delayed Price Updated: 1:45 PM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 999,925
Open 256.81
Bid (Size) 253.88 (1)
Ask (Size) 254.00 (1)
Prev. Close 258.60
Today's Range 253.69 - 259.44
52wk Range 177.05 - 264.97
Shares Outstanding 661,706,000
Dividend Yield 2.08%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Amgen To Webcast Investor Meeting At 2020 World Conference on Lung Cancer
Amgen (NASDAQ:AMGN) will host a webcast call for the investment community in conjunction with the 2020 World Conference on Lung Cancer (WCLC) on Friday, Jan. 29, at 8:00 p.m. ET. David M. Reese, M.D.,... 
From PR Newswire
Amgen To Showcase Next Frontier Of Innovation In Lung Cancer Therapies At WCLC 2020
Registrational Phase 2 Non-Small Cell Lung Cancer Results for Investigational KRAS G12C Inhibitor Sotorasib to be Featured in the Presidential Symposium 
From PR Newswire

Performance

YTD
+12.02%
+12.02%
1 Month
+13.53%
+13.53%
3 Month
+13.63%
+13.63%
6 Month
-0.53%
-0.53%
1 Year
+13.89%
+13.89%

More News

Read More
Amgen To Achieve Carbon Neutrality By 2027
From PR Newswire
Notable Wednesday Option Activity: AMGN, GRPN, ZNGA
Tags Stocks
From Market News Video
José M. Vega, M.D. Joins Moderna as Chief Safety Officer
From Business Wire News Releases
The January Effect
Tags Stocks / Equities
From Blogs - TalkMarkets
The 7 Best Healthcare Stocks to Buy for 2021
Tags ABT CERN BNTX
From InvestorPlace
Piclidenoson From Can-Fite Biopharma Shows New, Promising Developments For Psoriasis Treatment
Tags Can/Fite BioPharma Ltd/ NVS Market News
From Benzinga
GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease
From Business Wire News Releases
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines
From Business Wire News Releases
Bristol Myers Stock Is Eyeing A Buy Point At A 5-Year High — Is It A Buy?
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.